AQR Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Buy |
32,467
+6,158
| +23% | +$331K | ﹤0.01% | 2422 |
|
|
2025
Q4 | $1.28M | Buy |
26,309
+135
| +0.5% | +$5.26K | ﹤0.01% | 2417 |
|
|
2025
Q3 | $801K | Sell |
26,174
-1,548
| -6% | -$35.5K | ﹤0.01% | 2561 |
|
|
2025
Q2 | $615K | Sell |
27,722
-2,289
| -8% | -$47.9K | ﹤0.01% | 2493 |
|
|
2025
Q1 | $558K | Buy |
30,011
+18,165
| +153% | +$303K | ﹤0.01% | 2365 |
|
|
2024
Q4 | $157K | Sell |
11,846
-36,746
| -76% | -$890K | ﹤0.01% | 2711 |
|
|
2024
Q3 | $1.63M | Buy |
+48,592
| New | +$1.66M | ﹤0.01% | 1590 |
|
|
2024
Q2 | – | Sell |
-24,328
| Closed | -$548K | – | 2601 |
|
|
2024
Q1 | $548K | Buy |
24,328
+7,646
| +46% | +$181K | ﹤0.01% | 1931 |
|
|
2023
Q4 | $357K | Buy |
+16,682
| New | +$288K | ﹤0.01% | 2006 |
|
|
2022
Q2 | – | Sell |
-38,833
| Closed | -$961K | – | 2178 |
|
|
2022
Q1 | $961K | Sell |
38,833
-169
| -0.4% | -$5.12K | ﹤0.01% | 1562 |
|
|
2021
Q4 | $1.35M | Buy |
39,002
+12,657
| +48% | +$401K | ﹤0.01% | 1402 |
|
|
2021
Q3 | $714K | Buy |
26,345
+11,712
| +80% | +$297K | ﹤0.01% | 1726 |
|
|
2021
Q2 | $379K | Sell |
14,633
-8,541
| -37% | -$205K | ﹤0.01% | 1980 |
|
|
2021
Q1 | $499K | Sell |
23,174
-36,894
| -61% | -$931K | ﹤0.01% | 1837 |
|
|
2020
Q4 | $1.29M | Buy |
+60,068
| New | +$1.46M | ﹤0.01% | 1386 |
|
|
2019
Q1 | – | Sell |
-4,442
| Closed | -$283K | – | 2163 |
|
|
2018
Q4 | $283K | Sell |
4,442
-8,045
| -64% | -$598K | ﹤0.01% | 1982 |
|
|
2018
Q3 | $1.25M | Sell |
12,487
-20,938
| -63% | -$1.74M | ﹤0.01% | 1611 |
|
|
2018
Q2 | $2.38M | Buy |
33,425
+16,185
| +94% | +$1.36M | ﹤0.01% | 1347 |
|
|
2018
Q1 | $1.79M | Buy |
+17,240
| New | +$1.94M | ﹤0.01% | 1402 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
